BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 17942927)

  • 1. A human CD4 monoclonal antibody for the treatment of T-cell lymphoma combines inhibition of T-cell signaling by a dual mechanism with potent Fc-dependent effector activity.
    Rider DA; Havenith CE; de Ridder R; Schuurman J; Favre C; Cooper JC; Walker S; Baadsgaard O; Marschner S; vandeWinkel JG; Cambier J; Parren PW; Alexander DR
    Cancer Res; 2007 Oct; 67(20):9945-53. PubMed ID: 17942927
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HIV-1 glycoprotein gp120 disrupts CD4-p56lck/CD3-T cell receptor interactions and inhibits CD3 signaling.
    Hubert P; Bismuth G; Körner M; Debré P
    Eur J Immunol; 1995 May; 25(5):1417-25. PubMed ID: 7774645
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A humanised therapeutic CD4 mAb inhibits TCR-induced IL-2, IL-4, and IL-10 secretion and expression of CD25, CD40L, and CD69.
    Woods M; Guy R; Waldmann H; Glennie M; Alexander DR
    Cell Immunol; 1998 May; 185(2):101-13. PubMed ID: 9636688
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Revisiting the Timing of Action of the PAG Adaptor Using Quantitative Proteomics Analysis of Primary T Cells.
    Reginald K; Chaoui K; Roncagalli R; Beau M; Goncalves Menoita M; Monsarrat B; Burlet-Schiltz O; Malissen M; Gonzalez de Peredo A; Malissen B
    J Immunol; 2015 Dec; 195(11):5472-81. PubMed ID: 26512138
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interaction of CD4:lck with the T cell receptor/CD3 complex induces early signaling events in the absence of CD45 tyrosine phosphatase.
    Deans JP; Kanner SB; Torres RM; Ledbetter JA
    Eur J Immunol; 1992 Mar; 22(3):661-8. PubMed ID: 1532148
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibody-induced CD3-CD4 coligation inhibits TCR/CD3 activation in the absence of costimulatory signals in normal mouse CD4(+) T lymphocytes.
    Portolés P; de Ojeda G; Criado G; Fernández-Centeno E; Rojo JM
    Cell Immunol; 1999 Aug; 195(2):96-109. PubMed ID: 10448009
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD4+ CD45RA+ and CD4+ CD45RO+ T cells differ in their TCR-associated signaling responses.
    Hall SR; Heffernan BM; Thompson NT; Rowan WC
    Eur J Immunol; 1999 Jul; 29(7):2098-106. PubMed ID: 10427972
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Internalization of HIV glycoprotein gp120 is associated with down-modulation of membrane CD4 and p56lck together with impairment of T cell activation.
    Cefai D; Ferrer M; Serpente N; Idziorek T; Dautry-Varsat A; Debre P; Bismuth G
    J Immunol; 1992 Jul; 149(1):285-94. PubMed ID: 1535086
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The inositol 5-phosphatase SHIP-1 and adaptors Dok-1 and 2 play central roles in CD4-mediated inhibitory signaling.
    Waterman PM; Marschner S; Brandl E; Cambier JC
    Immunol Lett; 2012 Mar; 143(1):122-30. PubMed ID: 22370159
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In situ depletion of CD4+ T cells in human skin by Zanolimumab.
    Villadsen LS; Skov L; Dam TN; Dagnaes-Hansen F; Rygaard J; Schuurman J; Parren PW; van de Winkel JG; Baadsgaard O
    Arch Dermatol Res; 2007 Feb; 298(9):449-55. PubMed ID: 17091277
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HIV-1 down-regulates CD4 costimulation of TCR/CD3-directed tyrosine phosphorylation through CD4/p56lck dissociation.
    Kanner SB; Haffar OK
    J Immunol; 1995 Mar; 154(6):2996-3005. PubMed ID: 7876562
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Galectin-1 specifically modulates TCR signals to enhance TCR apoptosis but inhibit IL-2 production and proliferation.
    Vespa GN; Lewis LA; Kozak KR; Moran M; Nguyen JT; Baum LG; Miceli MC
    J Immunol; 1999 Jan; 162(2):799-806. PubMed ID: 9916701
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD4-independent signal transduction through the T-cell receptor (TCR/CD3).
    Granja CB; Gozashti CS; Dasgupta JD
    Immunology; 1994 Nov; 83(3):414-9. PubMed ID: 7835966
    [TBL] [Abstract][Full Text] [Related]  

  • 14. T cell receptor for antigen induces linker for activation of T cell-dependent activation of a negative signaling complex involving Dok-2, SHIP-1, and Grb-2.
    Dong S; Corre B; Foulon E; Dufour E; Veillette A; Acuto O; Michel F
    J Exp Med; 2006 Oct; 203(11):2509-18. PubMed ID: 17043143
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of tyrosine kinase p56lck with CD4 inhibits the induction of growth through the alpha beta T-cell receptor.
    Haughn L; Gratton S; Caron L; Sékaly RP; Veillette A; Julius M
    Nature; 1992 Jul; 358(6384):328-31. PubMed ID: 1322497
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Ick protein tyrosine kinase is not involved in antibody-mediated CD4 (CDR3-loop) signal transduction that inhibits HIV-1 transcription.
    Coudronnière N; Corbeil J; Robert-Hebmann V; Mesnard JM; Devaux C
    Eur J Immunol; 1998 May; 28(5):1445-57. PubMed ID: 9603449
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biological activities on T lymphocytes of a baculovirus-expressed chimeric recombinant IgG1 antibody with specificity for the CDR3-like loop on the D1 domain of the CD4 molecule.
    Troadec S; Bès C; Chentouf M; Nguyen B; Briant L; Jacquet C; Chebli K; Pugnière M; Roquet F; Cerutti M; Chardès T
    Clin Immunol; 2006 Apr; 119(1):38-50. PubMed ID: 16426893
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SLP-76 binding to p56lck: a role for SLP-76 in CD4-induced desensitization of the TCR/CD3 signaling complex.
    Sanzenbacher R; Kabelitz D; Janssen O
    J Immunol; 1999 Sep; 163(6):3143-52. PubMed ID: 10477581
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TCR-induced T cell activation leads to simultaneous phosphorylation at Y505 and Y394 of p56(lck) residues.
    Nyakeriga AM; Garg H; Joshi A
    Cytometry A; 2012 Sep; 81(9):797-805. PubMed ID: 22674786
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of IgG subclass antibodies and expression of T-Cell receptor signaling molecules in anti-CD4 monoclonal antibody treated mice with autoimmune cardiomyopathy.
    Wang Z; Liao YH; Yuan J; Zhang JH; Liu ZP; Dong JH
    Autoimmunity; 2006 Sep; 39(6):455-60. PubMed ID: 17060024
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.